KRT72 might serves as a prognostic biomarker for patients with prostate cancer

• Jie Wang,
• Yuhan Xiao,
• Qingxin Yu,
• Chi Zhang

Affiliations

Jie Wang

Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; West China School of medicine, West China Hospital, Sichuan University, Chengdu, 610041, China

Yuhan Xiao

Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; West China School of medicine, West China Hospital, Sichuan University, Chengdu, 610041, China

Qingxin Yu

Ningbo Diagnostic Pathology Center, Ningbo City, Zhejiang Province, China

Chi Zhang

Corresponding author. Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Guoxue Xiang #37, Chengdu, 610041, Sichuan, China.; Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, PR China